Search Results

According to a report by Decision Resources, 70.7% of patients who are newly diagnosed with Alzheimer's disease

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 573, 2009-03-07 , pp. 10-10(1)

Publisher: Adis International

Preventing Alzheimer's Disease: Separating Fact From Fiction

Authors: Sano, Mary; Grossman, Hillel; Kathleen Van Dyk,

Source: CNS Drugs, Volume 22, Number 11, 2008 , pp. 887-902(16)

Publisher: Adis International

Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease Not Affected by Co-Administration of Memantine: An Open-Label, Crossover, Single-Centre Study

Authors: Shua-Haim, Joshua; Smith, Juanita; Picard, Franck; Sedek, Greg; Athalye, Sandeep; Pommier, Françoise; Lefèvre, Gilbert

Source: Clinical Drug Investigation, Volume 28, Number 6, 2008 , pp. 361-374(14)

Publisher: Adis International

Rivastigmine transdermal patch: a guide to its use in dementia of the Alzheimer's type

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 4, APRIL 2008 , pp. 5-8(4)

Publisher: Adis International

Treatment of Cognitive Impairment in Multiple Sclerosis: Is the Use of Acetylcholinesterase Inhibitors a Viable Option?

Authors: Christodoulou, Christopher; MacAllister, William S.; McLinskey, Nancy A.; Krupp, Lauren B.

Source: CNS Drugs, Volume 22, Number 2, 2008 , pp. 87-97(11)

Publisher: Adis International

Drug-Induced Hyperhidrosis and Hypohidrosis: Incidence, Prevention and Management

Authors: Cheshire, William P.; Fealey, Robert D.

Source: Drug Safety, Volume 31, Number 2, 2008 , pp. 109-126(18)

Publisher: Adis International

Rivastigmine Transdermal Patch: In the Treatment of Dementia of the Alzheimer's Type

Authors: Yang, Lily P.H.; Keating, Gillian M.

Source: CNS Drugs, Volume 21, Number 11, 2007 , pp. 957-965(9)

Publisher: Adis International

Judgement in favour of NICE Alzheimer's recommendations

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 535, 2007-08-25 , pp. 14-14(1)

Publisher: Adis International

Memantine Pharmacotherapy: A Naturalistic Study Using a Population Pharmacokinetic Approach

Authors: Kornhuber, Johannes; Kennepohl, Evelin M.; Bleich, Stefan; Wiltfang, Jens; Kraus, Thomas; Reulbach, Udo; Meineke, Ingolf

Source: Clinical Pharmacokinetics, Volume 46, Number 7, 2007 , pp. 599-612(14)

Publisher: Adis International

New drug treatments for AD could save US trillions

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 529, 2007-06-02 , pp. 14-14(1)

Publisher: Adis International

Tolerability, Safety and Pharmacokinetics of the FGL_L Peptide, a Novel Mimetic of Neural Cell Adhesion Molecule, Following Intranasal Administration in Healthy Volunteers

Authors: Anand, Ravi; Seiberling, Michael; Kamtchoua, Thierry; Pokorny, Rolf

Source: Clinical Pharmacokinetics, Volume 46, Number 4, 2007 , pp. 351-358(8)

Publisher: Adis International

NICE guidance for dementia drugs: flow-on effects

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 524, 2007-03-24 , pp. 4-4(1)

Publisher: Adis International

Naturalistic Treatment of Alzheimer's Disease with Galantamine: 12-Month Follow-Up from the NATURE Study

Authors: Brodaty, Henry; Woodward, Michael; Boundy, Karyn; Barnes, Nicola

Source: CNS Drugs, Volume 21, Number 4, 2007 , pp. 335-336(2)

Publisher: Adis International

The National Institute for Health and Clinical Excellence (NICE) and Drug Treatment for Alzheimer's Disease

Author: Iliffe, Steve

Source: CNS Drugs, Volume 21, Number 3, 2007 , pp. 177-184(8)

Publisher: Adis International

A Naturalistic Study of Galantamine for Alzheimer's Disease

Authors: Brodaty, Henry; Woodward, Michael; Boundy, Karyn; Barnes, Nicola; Allen, Gabrielle

Source: CNS Drugs, Volume 20, Number 11, 2006 , pp. 935-943(9)

Publisher: Adis International

Added Therapeutic Value of Memantine in the Treatment of Moderate to Severe Alzheimer's Disease

Authors: Heinen-Kammerer, T.; Rulhoff, H.; Nelles, S.; Rychlik, R.

Source: Clinical Drug Investigation, Volume 26, Number 6, 2006 , pp. 303-314(12)

Publisher: Adis International

Drugs to treat Alzheimer's, pain, diabetes show growth potential

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 513, 2006-10-07 , pp. 10-10(1)

Publisher: Adis International

Changes in Metabolite Ratios after Treatment with Rivastigmine in Alzheimer's Disease: A Nonrandomised Controlled Trial with Magnetic Resonance Spectroscopy

Authors: Modrego, Pedro J.; Pina, Miguel A.; Fayed, Nicolás; Díaz, Marcos

Source: CNS Drugs, Volume 20, Number 10, 2006 , pp. 867-877(11)

Publisher: Adis International

Galantamine Extended Release

Authors: Robinson, Dean M.; Plosker, Greg L.

Source: CNS Drugs, Volume 20, Number 8, 2006 , pp. 673-681(9)

Publisher: Adis International

Galantamine Extended Release: A Viewpoint by Martin R. Farlow

Author: Farlow, Martin R.

Source: CNS Drugs, Volume 20, Number 8, 2006 , pp. 682-683(2)

Publisher: Adis International